Purohit Neha, Chugh Yashika, Bahuguna Pankaj, Prinja Shankar
Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Health Policy Technol. 2022 Jun;11(2):100636. doi: 10.1016/j.hlpt.2022.100636. Epub 2022 May 5.
We undertook the study to present a comprehensive overview of COVID-19 related measures, largely centred around the development of vaccination related policies, their implementation and challenges faced in the vaccination drive in India.
A targeted review of literature was conducted to collect relevant data from official government documents, national as well as international databases, media reports and published research articles. The data were summarized to assess Indian government's vaccination campaign and its outcomes as a response to COVID-19 pandemic.
The five-point strategy adopted by government of India was "COVID appropriate behaviour, test, track, treat and vaccinate". With respect to vaccination, there have been periodic shifts in the policies in terms of eligible beneficiaries, procurement, and distribution plans, import and export strategy, involvement of private sector and use of technology. The government utilized technology for facilitating vaccination for the beneficiaries and monitoring vaccination coverage.
The monopoly of central government in vaccine procurement resulted in bulk orders at low price rates. However, the implementation of liberalized policy led to differential pricing and delayed achievement of set targets. The population preference for free vaccines and low profit margins for the private sector due to price caps resulted in a limited contribution of the dominant private health sector of the country. A wavering pattern was observed in the vaccination coverage, which was related majorly to vaccine availability and hesitancy. The campaign will require consistent monitoring for timely identification of bottlenecks for the lifesaving initiative.
我们开展这项研究,旨在全面概述与新冠疫情相关的措施,主要围绕疫苗接种相关政策的制定、实施以及印度疫苗接种运动中面临的挑战。
进行有针对性的文献综述,以从官方政府文件、国家和国际数据库、媒体报道以及已发表的研究文章中收集相关数据。对数据进行总结,以评估印度政府针对新冠疫情的疫苗接种运动及其成果。
印度政府采用的五点战略是“新冠疫情适当行为、检测、追踪、治疗和接种疫苗”。在疫苗接种方面,在 eligible beneficiaries( eligible beneficiaries 可能有误,结合语境推测应为“ eligible beneficiaries”,即符合条件的受益者)、采购、分发计划、进出口战略、私营部门的参与以及技术使用等政策方面存在周期性变化。政府利用技术为受益者提供疫苗接种便利并监测疫苗接种覆盖率。
中央政府在疫苗采购方面的垄断导致以低价大量订购。然而,自由化政策的实施导致了差异化定价并延迟实现既定目标。由于价格上限,民众对免费疫苗的偏好以及私营部门利润率较低,导致该国占主导地位的私营卫生部门贡献有限。疫苗接种覆盖率呈现波动模式,这主要与疫苗供应和犹豫情绪有关。该运动将需要持续监测,以便及时识别这项救生举措的瓶颈。 (需注意,原文中“eligible beneficiaries”疑似有误,可能影响译文准确性)